In this study, serum concentration of IL-6 was higher in oral cancer patients when compared to the controls which was also confirmed in other studies (4,6,8,17) Furthermore, the results of this study show that serum IL-6 was an independent risk factor for the disease recurrence. This evidence concerns the gene IL6 and lip and oral cavity carcinoma.